QTMeds

DETRUSITOL 2 mg

Clinical Description (Database Summary)

At recommended and supratherapeutic tolterodine doses, mean QTcF prolongation and 5.0 and 11.8 ms respectively.

Scientific Sources / References

https://doi.org/10.1038/sj.clpt.6100089